# GOALS & OBJECTIVES

**Measurable Outcomes for Medical Knowledge Democratization**

---

[← Previous: Statement of Need](./01_STATEMENT_OF_NEED.md) | [Back to Index](./00_GRANT_PROPOSAL_INDEX.md) | [Next: Methodology →](./03_METHODOLOGY_IMPLEMENTATION.md)

**Status**: ✅ Complete
**Word Count**: ~5,000 words
**Last Updated**: November 9, 2025

---

## Executive Summary

This section outlines specific, measurable, achievable, relevant, and time-bound (SMART) objectives for the Uniting Doctors platform over a 24-month grant period. Our goals are organized into four pillars:

1. **Platform Development**: Build secure, scalable, user-friendly infrastructure
2. **Community Building**: Engage medical professionals globally
3. **Health Impact**: Improve patient outcomes through earlier diagnosis and knowledge sharing
4. **Research & Evaluation**: Document impact and contribute to medical knowledge

Each objective includes clear success metrics, evaluation methods, and accountability measures.

---

## Primary Mission

**Eliminate preventable suffering caused by medical knowledge silos through global healthcare professional collaboration, with founding focus on rare disease awareness and earlier diagnosis.**

### Core Values Underlying Our Goals

1. **Evidence-Based**: All platform discussions grounded in research and citations
2. **Patient-Centered**: Every feature designed to ultimately improve patient care
3. **Globally Equitable**: Knowledge access based on need, not ability to pay
4. **Community-Governed**: Users have voice in platform direction
5. **Measurably Impactful**: Clear metrics for health outcomes, not just vanity metrics

---

## Year 1 Goals (Months 1-12)

### 1. Platform Development Goals

#### Objective 1.1: Launch HIPAA-Compliant Web Platform

**Specific Target**: Fully functional web application with core social features

**Measurable Deliverables**:

- ✅ User registration and authentication (OAuth 2.0)
- ✅ Medical license verification system (automated NPI validation + manual review)
- ✅ Discussion board (posts, comments, voting, nested threads)
- ✅ Specialty-based communities (50+ groups created)
- ✅ User profiles with reputation tracking
- ✅ Content moderation system (AI + human review)
- ✅ Search functionality (basic text search)
- ✅ Notification system (email + in-app)
- ✅ Mobile-responsive design (works on phones/tablets)
- ✅ HIPAA compliance (encryption, audit logs, BAAs)

**Success Metrics**:

- Platform uptime: ≥99.5% (excluding planned maintenance)
- Page load time: <3 seconds (p95)
- Zero HIPAA violations
- Security audit passed (penetration testing)

**Timeline**:

- Months 1-2: Infrastructure setup, authentication
- Months 3-4: Core features (posts, comments, voting)
- Month 5: Content moderation, verification
- Month 6: Beta launch with 500 users
- Months 7-12: Iteration based on feedback

**Responsible Party**: Chief Technology Officer + Engineering team

**Evaluation Method**: Technical testing, security audit, user acceptance testing

---

#### Objective 1.2: Integrate PubMed Research Database

**Specific Target**: Seamless access to 30+ million medical research papers

**Measurable Deliverables**:

- ✅ PubMed E-utilities API integration
- ✅ Research paper search within platform
- ✅ Automatic daily research feeds by specialty (50+ specialties)
- ✅ Personal research library (save, tag, annotate papers)
- ✅ Citation formatting and export
- ✅ Link research papers to relevant discussions

**Success Metrics**:

- 10,000+ research papers shared in first year
- 30% of users engage with research features monthly
- Average 2+ papers saved per active user per month

**Timeline**: Months 4-8

**Responsible Party**: Engineering team + Medical Advisory Board (specialty feeds)

**Evaluation Method**: Usage analytics, user surveys

---

#### Objective 1.3: Deploy AI-Powered Content Moderation

**Specific Target**: Automated detection of HIPAA violations and harmful content

**Measurable Deliverables**:

- ✅ PHI detection (regex patterns + medical NER model)
- ✅ Toxicity detection (Perspective API integration)
- ✅ Misinformation flagging (GPT-4 powered, medical fact-checking)
- ✅ Manual review queue for flagged content
- ✅ User reporting mechanism
- ✅ Transparent moderation policies published

**Success Metrics**:

- PHI detection accuracy: ≥95% (validated on test dataset)
- False positive rate: <5%
- Moderation SLA: Critical content reviewed within 1 hour
- Zero PHI exposure incidents

**Timeline**: Months 5-9

**Responsible Party**: ML Engineer + Medical Moderators

**Evaluation Method**: Accuracy testing, incident tracking, user reports

---

### 2. Community Building Goals

#### Objective 2.1: Verify and Onboard 25,000 Medical Professionals

**Specific Target**: Diverse, engaged user base representing multiple specialties and geographies

**Measurable Deliverables**:

- ✅ 25,000+ verified users by Month 12
- ✅ Demographic diversity:
  - 50+ specialties represented
  - 30% from rural or underserved areas
  - 20% from outside North America
  - 40% non-physician healthcare professionals (nurses, PAs, pharmacists)
  - 25% women (reflecting medical workforce demographics)
  - 10% medical students/residents

**Success Metrics**:

- User growth: 1,000 (Month 3) → 5,000 (Month 6) → 15,000 (Month 9) → 25,000 (Month 12)
- Verification rate: ≥95% of applicants successfully verified within 3 days
- Geographic diversity: ≥20 countries represented

**Timeline**: Months 1-12 (ongoing)

**Responsible Party**: Community Manager + Verification team

**Evaluation Method**: User database analysis, demographic surveys

---

#### Objective 2.2: Achieve Strong User Engagement

**Specific Target**: Active, returning user community (not just sign-ups)

**Measurable Metrics**:

- **Daily Active Users (DAU) / Monthly Active Users (MAU)**: ≥20% by Month 12
- **7-day retention**: ≥40% (% of users who return within 7 days)
- **30-day retention**: ≥30% (% of users who return within 30 days)
- **Posts per day**:
  - Month 6: 50+ posts/day
  - Month 12: 200+ posts/day
- **Comments per post**: Average 5+ comments
- **Session duration**: 10-15 minutes average
- **Return frequency**: 2-3 times per week for active users

**Success Metrics**:

- 100,000+ total posts in Year 1
- 500,000+ total comments in Year 1
- 50,000+ total votes (upvotes/downvotes)

**Timeline**: Measured continuously from Month 3 (beta launch)

**Responsible Party**: Community Manager + Product team

**Evaluation Method**: Platform analytics dashboard, cohort analysis

---

#### Objective 2.3: Establish 50+ Specialty Communities

**Specific Target**: Critical mass in key specialties for meaningful discussions

**Measurable Deliverables**:

- ✅ 50+ specialty groups created and moderated
- ✅ Priority specialties (target 500+ members each by Month 12):
  - Pulmonology (AATD focus)
  - Primary Care / Family Medicine
  - Internal Medicine
  - Emergency Medicine
  - Pediatrics
  - Cardiology
  - Oncology
  - Rare Diseases (10+ specific disease communities)

**Success Metrics**:

- All 50 specialty groups have ≥50 members by Month 12
- Top 10 specialty groups have ≥500 members each
- 70% of users active in ≥1 specialty group
- Average user member of 3 specialty groups

**Timeline**: Months 4-12

**Responsible Party**: Community Manager + Medical Advisory Board

**Evaluation Method**: Group membership analytics, activity metrics

---

### 3. Health Impact Goals

#### Objective 3.1: AATD Awareness Campaign - Educate 100,000+ Medical Professionals

**Specific Target**: Measurable increase in AATD awareness among platform users and beyond

**Measurable Deliverables**:

- ✅ 50+ clinical discussions focused on AATD (cases, diagnostics, management)
- ✅ 5,000+ AATD-related posts, comments, and interactions
- ✅ 10+ educational content pieces (articles, videos, infographics)
- ✅ 100,000+ healthcare professionals reached through platform and partner channels
- ✅ Virtual AMA (Ask Me Anything) with AATD specialist (500+ attendees)
- ✅ Presentation at American Thoracic Society conference (Abstract accepted)

**Success Metrics**:

- Pre/post knowledge assessment:
  - Baseline: 23% of PCPs can correctly describe AATD
  - Target: 50% of platform users can correctly describe AATD (Month 12)
- Behavioral change:
  - 25% increase in Alpha-1 testing rates in partner institutions
  - 100+ users report "considered AATD for first time due to platform"

**Timeline**: Months 6-12 (after platform launched)

**Responsible Party**: Chief Medical Officer + Mark Egly + Alpha-1 Foundation

**Evaluation Method**: Pre/post surveys, partner institution data, user testimonials

---

#### Objective 3.2: Facilitate 100,000+ Clinical Discussions

**Specific Target**: High-quality knowledge sharing improving clinical decision-making

**Measurable Deliverables**:

- ✅ 100,000+ total posts/comments by Month 12
- ✅ Discussion categories:
  - Clinical questions (30%)
  - Case discussions (20%)
  - Research paper discussions (15%)
  - Clinical guidelines (10%)
  - Professional development (10%)
  - Rare diseases (5%)
  - Other (10%)

**Success Metrics**:

- 75% of clinical questions receive ≥1 quality answer within 24 hours
- 40% of users report "changed clinical practice based on platform discussion"
- 60% of users report "learned something clinically useful" monthly
- Average evidence level: 70% of discussions cite research (not just opinion)

**Timeline**: Months 6-12

**Responsible Party**: Community Manager + Medical Moderators

**Evaluation Method**: Content analysis, user surveys, engagement metrics

---

#### Objective 3.3: Document Earlier Rare Disease Diagnoses

**Specific Target**: Measurable patient impact through case studies

**Measurable Deliverables**:

- ✅ 500+ documented cases where platform discussion contributed to earlier diagnosis
- ✅ Focus areas:
  - AATD: 200+ cases
  - Other rare diseases: 300+ cases
- ✅ 50+ detailed case studies collected (patient outcomes, time saved)
- ✅ Partner with Alpha-1 Foundation to track diagnostic rates

**Success Metrics**:

- Average diagnostic time reduction: ≥25% for AATD cases
- 50+ physician testimonials: "This platform helped me diagnose..."
- Patient impact: 500+ patients diagnosed earlier, avoiding preventable complications

**Timeline**: Months 9-12 (after sufficient community size)

**Responsible Party**: Chief Medical Officer + Research team

**Evaluation Method**: User-reported case studies, partner institution data, surveys

---

### 4. Research & Evaluation Goals

#### Objective 4.1: Establish Comprehensive Evaluation Framework

**Specific Target**: Rigorous methodology for measuring platform impact

**Measurable Deliverables**:

- ✅ Evaluation plan with specific metrics, data collection methods
- ✅ Partner with external evaluator (academic institution or research firm)
- ✅ Baseline data collected (pre-platform metrics)
- ✅ Dashboard tracking key metrics in real-time
- ✅ Quarterly evaluation reports
- ✅ Annual comprehensive impact report

**Success Metrics**:

- Evaluation framework approved by Medical Advisory Board
- Data collection systems operational by Month 3
- 100% of planned data collected

**Timeline**: Months 1-3 (setup), ongoing data collection

**Responsible Party**: Chief Medical Officer + External evaluator

**Evaluation Method**: Peer review of methodology, data completeness audit

---

#### Objective 4.2: Publish Research Findings

**Specific Target**: Contribute to medical literature on knowledge sharing and digital health

**Measurable Deliverables**:

- ✅ 3+ peer-reviewed publications submitted by Month 12
  - Paper 1: "Platform design and user engagement metrics" (6-month data)
  - Paper 2: "Impact of online community on AATD diagnostic rates" (12-month data)
  - Paper 3: "Patterns of medical knowledge sharing in online communities"
- ✅ 5+ conference presentations (ATS, AMA, HIMSS, etc.)
- ✅ White paper on rare disease awareness campaigns (publicly available)

**Success Metrics**:

- ≥1 paper accepted in peer-reviewed journal by Month 12
- ≥3 conference presentations delivered
- 10,000+ downloads of public reports

**Timeline**: Months 6-12 (after sufficient data)

**Responsible Party**: Chief Medical Officer + Academic partners

**Evaluation Method**: Publication tracking, citation analysis

---

## Year 2 Goals (Months 13-24)

### 1. Platform Development Goals

#### Objective 1.4: Launch Mobile Applications (iOS & Android)

**Specific Target**: Native mobile apps with feature parity to web platform

**Measurable Deliverables**:

- ✅ iOS app launched in App Store
- ✅ Android app launched in Google Play
- ✅ Push notifications for engagement
- ✅ Offline reading mode
- ✅ Biometric authentication
- ✅ Image upload and medical photo sharing

**Success Metrics**:

- 25,000+ total app downloads by Month 24
- 50% of active users use mobile app at least once per week
- App store ratings: ≥4.5 stars

**Timeline**: Months 13-18 (development), Month 19 (launch)

**Responsible Party**: Mobile development team

---

#### Objective 1.5: Deploy AI-Powered Advanced Features

**Specific Target**: Cutting-edge AI to enhance user experience

**Measurable Deliverables**:

- ✅ Diagnosis assistant (GPT-4 powered differential diagnosis suggestions)
- ✅ Research paper summarization (automatic TL;DR)
- ✅ Semantic search (BioBERT embeddings, find similar discussions)
- ✅ Personalized content recommendations
- ✅ Trending topics detection

**Success Metrics**:

- 30% of users engage with AI features monthly
- AI diagnosis assistant used 1,000+ times/month
- User satisfaction with AI features: ≥70%

**Timeline**: Months 15-22

---

#### Objective 1.6: Launch Off-Label Medication Database

**Specific Target**: Crowdsourced real-world evidence for off-label uses

**Measurable Deliverables**:

- ✅ User-reported off-label use cases
- ✅ Outcome tracking (positive, neutral, negative)
- ✅ Aggregate success rates
- ✅ Supporting research citations
- ✅ Prominent disclaimers on all content

**Success Metrics**:

- 1,000+ off-label uses documented
- 5,000+ outcome reports
- 100+ medications with ≥10 reports each

**Timeline**: Months 18-24

---

### 2. Community Building Goals

#### Objective 2.4: Scale to 100,000 Verified Users

**Measurable Targets**:

- 100,000+ total users by Month 24
- 50+ countries represented
- 150+ specialty communities active
- 25% of users from developing countries (free premium access)

**Success Metrics**:

- Sustained growth: 3,000-5,000 new users/month
- Retention maintained: ≥30% 30-day retention
- Engagement: ≥25% DAU/MAU

**Timeline**: Months 13-24 (ongoing)

---

#### Objective 2.5: Establish 50+ Medical School Partnerships

**Specific Target**: Integration into medical education

**Measurable Deliverables**:

- ✅ 50+ medical schools providing student access
- ✅ 10,000+ medical students/residents as users
- ✅ 5+ schools integrate platform into curriculum
- ✅ Educational content developed for students

**Success Metrics**:

- Student engagement: 40% of student users active monthly
- Faculty participation: 500+ faculty members active
- Curriculum integration: 5+ schools formally adopt

**Timeline**: Months 13-24

---

### 3. Health Impact Goals

#### Objective 3.4: Document 5,000+ Earlier Rare Disease Diagnoses

**Specific Target**: Scale impact beyond AATD to 100+ rare diseases

**Measurable Deliverables**:

- ✅ 5,000+ documented cases of earlier diagnosis
- ✅ Active communities for 100+ rare diseases
- ✅ Partnership with 20+ disease advocacy organizations
- ✅ Systematic awareness campaigns for top 10 rare diseases

**Success Metrics**:

- AATD diagnostic rate improvement: 50% reduction in diagnostic delay
- 100+ rare diseases with active discussions
- Patient impact: 5,000+ patients diagnosed earlier

**Timeline**: Months 13-24

---

#### Objective 3.5: Demonstrate Healthcare Cost Savings

**Specific Target**: $250 million in documented savings

**Measurable Approach**:

- Model cost of late diagnosis prevented
- Calculate savings from error prevention
- Estimate reduced unnecessary testing
- Conservative assumptions, peer-reviewed methodology

**Success Metrics**:

- $250M+ total estimated healthcare savings
- Methodology validated by health economists
- Published in peer-reviewed health economics journal

**Timeline**: Months 18-24

---

### 4. Research & Evaluation Goals

#### Objective 4.3: Publish 10+ Research Papers

**Target Publications**:

1. Platform effectiveness for knowledge dissemination
2. AATD diagnostic rate improvement study
3. Multi-center rare disease awareness campaign outcomes
4. Off-label medication database validation study
5. Physician burnout reduction through online community
6. Patterns of medical knowledge sharing
7. Real-world evidence aggregation at scale
8. Digital health platform design for medical professionals
9. Health economics of early rare disease diagnosis
10. Telemedicine consultation outcomes

**Timeline**: Months 13-24

---

#### Objective 4.4: Present at Major Medical Conferences

**Target Conferences**:

- American Thoracic Society (ATS) - 60K attendees
- American Medical Association (AMA) Annual Meeting
- Healthcare Information and Management Systems Society (HIMSS)
- American College of Physicians (ACP) Internal Medicine Meeting
- Rare Disease Day events globally
- 10+ total conference presentations

**Timeline**: Months 13-24

---

## Long-Term Vision (Years 3-5)

### Year 3 Goals Summary

- 250,000 verified users
- Path to financial sustainability (60% earned revenue)
- 15+ languages supported
- EHR integration pilots (Epic, Cerner)
- 25% reduction in research-to-practice lag (measured)

### Year 5 Goals Summary

- 500,000 verified users
- Financially sustainable (75% earned revenue)
- 50,000+ lives improved through earlier diagnosis
- $2 billion+ healthcare savings documented
- Standard tool integrated into medical education globally

---

## Goal Alignment with Grant Priorities

### If Applying to Health Foundation

**Emphasis**:

- Patient outcomes (earlier diagnosis, reduced errors)
- Health equity (rural access, developing world)
- Healthcare cost savings

### If Applying to Technology Foundation

**Emphasis**:

- Platform innovation (AI, semantic search)
- Open-source contributions
- Digital health infrastructure

### If Applying to Government Grant (NIH, AHRQ)

**Emphasis**:

- Research methodology and publications
- Multi-center studies
- Health services research
- Evidence-based outcomes

### If Applying to Disease-Specific Foundation

**Emphasis**:

- AATD awareness and diagnostic rates
- Rare disease patient advocacy
- Measurable patient impact

---

## Accountability and Reporting

### Quarterly Progress Reports

- Metrics dashboard (all KPIs)
- User growth and engagement
- Health impact case studies
- Financial status
- Challenges and mitigation strategies
- Upcoming milestones

### Annual Comprehensive Impact Report

- Full evaluation findings
- Patient stories
- Research publications
- Financial statements
- Strategic adjustments for next year

### Real-Time Transparency

- Public metrics dashboard (aggregate data)
- Monthly newsletter to stakeholders
- Open-source code repository
- Published moderation transparency reports

---

## Success Criteria: How We'll Know We've Succeeded

### By End of Month 12

✅ 25,000+ verified users, 40% 30-day retention
✅ 100,000+ clinical discussions
✅ 100K+ medical professionals educated about AATD
✅ 500+ documented earlier diagnoses
✅ 3+ research papers submitted
✅ Zero HIPAA violations
✅ Platform uptime >99.5%
✅ User NPS score >40

### By End of Month 24

✅ 100,000+ verified users, 30% 30-day retention
✅ 50+ medical school partnerships
✅ Mobile apps launched (25K+ downloads)
✅ 5,000+ earlier rare disease diagnoses
✅ $250M+ healthcare savings documented
✅ 10+ research publications
✅ Path to financial sustainability established

### By End of Year 5

✅ 500,000+ users, self-sustaining financially
✅ 50,000+ lives improved
✅ Research-to-practice gap measurably reduced
✅ Standard tool in medical education
✅ Global impact in 100+ countries

---

## Conclusion

These goals are ambitious but achievable with adequate funding and partnerships. Every objective directly contributes to our mission: **eliminating preventable suffering caused by medical knowledge silos.**

We've designed goals to be:

- **Specific**: Clear deliverables, not vague aspirations
- **Measurable**: Quantitative metrics, validated by external evaluators
- **Achievable**: Based on realistic projections and comparable platforms
- **Relevant**: Aligned with funder priorities and mission
- **Time-Bound**: Clear milestones at 6, 12, 18, 24 months

**Most importantly**: Our goals are **patient-centered**. Every feature we build, every user we onboard, every discussion facilitated exists to ultimately improve patient care and save lives.

With your support, we can achieve these goals and transform medical knowledge sharing globally.

---

[← Previous: Statement of Need](./01_STATEMENT_OF_NEED.md) | [Back to Index](./00_GRANT_PROPOSAL_INDEX.md) | [Next: Methodology →](./03_METHODOLOGY_IMPLEMENTATION.md)

**Questions about our goals?**
grants@unitingdoctors.org
